Ubs Group Ag Bionomics Limited Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Bionomics Limited stock. As of the latest transaction made, Ubs Group Ag holds 34,897 shares of BNOX stock, worth $18,495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,897
Previous 9,933
251.32%
Holding current value
$18,495
Previous $10,000
160.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BNOX
# of Institutions
12Shares Held
1.64MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.23MShares$650,1820.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct316KShares$167,4800.0% of portfolio
-
Two Sigma Securities, LLC New York, NY26KShares$13,8000.0% of portfolio
-
Two Sigma Investments, LP New York, NY16.4KShares$8,6760.0% of portfolio
-
Xtx Topco LTD London, X010.9KShares$5,7980.0% of portfolio
About BIONOMICS LIMITED
- Ticker BNOX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,518,620
- Market Cap $3.98M
- Description
- Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...